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     Introduction  We have previously observed bone marrow (BM) hypo-
plasia in a murine model of chronic smoking, which was ameliorated by mu-
rine adipose-derived stromal cells (ASC). This study was designed to test 
the hypothesis that ASC exert their marrow protective effects through key 
paracrine factors. Methods  Mice (NSG or C57BL/6) were exposed to ciga-
rette smoke (CS) for 1 day to 6 months. Human ASC or ASC conditioned 
media were administered through intravenous (i.v.) or intraperitoneal (i.p.) 
injections. Secretion of TSG-6 from ASC in response to TNF alpha and IL-1 
beta were measured by ELISA. Expression of TSG-6 in ASC was knocked 
down by siRNA. BM hematopoietic progenitors were quantified by colony 
forming-unit assays. Possible engrafted human ASC in mouse BM were ex-
amined by anti-human nuclei staining. Results The myelossupressive effect 
of cigarette smoking occurred acutely (1 day: 65.6% of nonsmoking control, 
NSC, p<0.01) and worsened with prolonged exposure (3 days: 34.3% NSC, 
p<0.01). Such damage could be ameliorated with either ASC (111.0% NSC, 
p>0.05) or ASC conditioned media (105.7% NSC, p>0.05). Inflammatory 
cytokines (TNF alpha and IL-1 beta) elevated in smokers (Kuschner et al, 
1996; de Maat et al, 2002) demonstrated strong cross-species stimulatory 
effects on secretions of an anti-inflammatory cytokine, TSG-6 from ASC 
(TNF alpha: 8.7 +/- 1.3 fold, IL-1 beta: 8.2 +/- 1.1 fold). Knocking down 
TSG-6 (>90%) abolished the marrow-protective effect of ASC. No human 
cells were detected in recipient mouse bone marrow. Conclusions The pro-
tective effects of ASC against smoking-induced myelosuppression are medi-
ated by trophic factors rather than cell engraftment or differentiation. TSG-6 
appears to play a significant role in the modulatory pathway: smoke--
inflammatory cytokine release--TSG6 secretion from ASC--bone marrow 
protection. 
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